Sobre 2 señales de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Browse the detailed record of transactions filed by Strobeck Matthew, Consejero. Director active across 5 companies, notably QUIDEL CORP. Cumulatively, 21 reports have been logged. Split: 7 buys · 0 sell. Total volume traded: €2.6m. History available since 12 May 2021. The latest transaction was filed on 13 February 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Strobeck Matthew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Strobeck Matthew is Administrateur at QuidelOrtho Corp, BIODESIX INC, Accelerate Diagnostics, Inc, QUIDEL CORP and METABOLIX, INC. The record shows 21 filings, and the sampled recent filings, from 2016-01-28 to 2026-02-13, show EUR 2626486 of buys and EUR 0 of sells, with transaction nature listed as Attribution.